Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )
ClinResearch, which will now operate under the name UBC ClinResearch, willbe a centerpiece of UBC's adaptive design clinical trial offering and willdeliver a full service, global solution for pharmaceutical, biotechnology andmedical device companies seeking to capitalize on the benefits of adaptivedesign in their clinical development strategy.
Advertisement
"We are thrilled to welcome ClinResearch to the UBC family," said EthanLeder, CEO of UBC. "Having worked with the founders for several years, we knowthat they are an excellent fit with our culture and vision. They areinnovative and science driven, and have built a world-class organization witha track record of developing and executing technology solutions that we planto introduce aggressively to our growing base of sponsor and CRO clients."
"The interest in adaptive design is accelerating from the early adopter tothe rapid growth stage. We are excited to be joining an organization with theresources to allow us to capitalize on this opportunity," noted MichaelFischer, PhD, founder of ClinResearch. Fischer added, "We are moving forwardwith expansion plans to fulfill demand on our global projects with UBC andanticipate growth in Cologne, as well as in our offices in Russia and theUkraine to benefit our clients."
According to Patrick Lindsay, Executive Vice President of UBC,"ClinResearch's leadership in adaptive design is consistent with UBC's focuson innovative solutions for clinical development. Reinhard Eisebitt,ClinResearch's co-founder, is recognized by the FDA and European regulatoryauthorities as a thought leader in adaptive design based on the proprietarysoftware and techniques that he helped develop. We look forward to bringingour combined strengths in this novel and quickly evolving methodology to theindustry." The ClinResearch announcement is the latest in a series oftransactions made since UBC raised $153 million in equity capital from asyndicate of leading private equity firms in 2003.
Since 1999, ClinResearch, GmbH, headquartered in Cologne, Germany, hasbeen a leader in planning, conducting and reporting clinical studies for thepharmaceutical and medical device industries. For more information, visitwww.clinresearch.com.
United BioSource Corporation (UBC) is a global pharmaceutical servicesorganization that helps emerging and established life science companiesdevelop and commercialize medical products. UBC specializes in offering newand innovative ways to study drugs and devices by offering expertise inscience, strategy and execution.
UBC is headquartered in Bethesda, Maryland, with offices in the UnitedStates, Canada, Europe and South America. For more information, visitwww.unitedbiosource.com or call 866-458-1096.
CONTACT: Tess Drahzal, +1 (240) 644-0420, [email protected]
SOURCE United BioSource Corporation
